Use and efficacy of antifibrinolytic agents in patients undergoing growth-friendly surgery for neuromuscular scoliosis
AF agents are being used for patients undergoing growth-friendly procedures with TXA being the most commonly used AF. However, there is no significant difference in EBL, cell saver volume, and intraoperative or postoperative transfusion rates between patients that do or do not receive AF agents for these procedures. Additional studies are needed to validate these results, as well as determine their efficacy, safety, and value in this medically fragile group.
Authors
- Ishaan Swarup (ORCID: https://orcid.org/0000-0003-3481-3408)
- John D. Smith (ORCID: https://orcid.org/0009-0003-7827-8280)
- Jasmine Dosanjh
- Paul D. Sponseller (ORCID: https://orcid.org/0000-0003-2934-6374)
- Peter Strum
- Wei Wu (ORCID: https://orcid.org/0009-0004-5831-6953)
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- Johns Hopkins University (US)
- University of California, San Francisco (US)
- Johns Hopkins Medicine (US)
- UCSF Benioff Children's Hospital (US)
Publication Details
- Journal
- Spine Deformity
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1007/s43390-025-01214-9
- Primary Topic
- Cardiac, Anesthesia and Surgical Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00